- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 407/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 407/04
Total number of patents in this class: 711
10-year publication summary
|
59
|
48
|
42
|
47
|
51
|
40
|
50
|
34
|
39
|
18
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
25 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Janssen Pharmaceutica N.V. | 3839 |
11 |
| LG Chem, Ltd. | 17205 |
9 |
| Syngenta Participations AG | 4970 |
9 |
| Green Cross Corporation | 179 |
9 |
| Novartis AG | 11238 |
8 |
| Hoffmann-La Roche Inc. | 3060 |
8 |
| BASF SE | 19740 |
8 |
| Daewoong Pharmaceutical Co., Ltd. | 283 |
8 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 118 |
8 |
| JNC Corporation | 1527 |
8 |
| SynDevRx, Inc. | 43 |
8 |
| Bristol-myers Squibb Company | 5080 |
7 |
| JNC Petrochemical Corporation | 425 |
7 |
| Blade Therapeutics, Inc. | 23 |
6 |
| FMC Corporation | 910 |
6 |
| Samsung Display Co., Ltd. | 30585 |
5 |
| Syngenta Limited | 509 |
5 |
| Centre National de La Recherche Scientifique | 9632 |
5 |
| Other owners | 540 |